Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05613647

Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring

Conditions: Shock, Acute Circulatory Failure, Hemodynamic Monitoring

Sex: All
Ages: 18 Years – N/A
Enrollment: 15
Sponsor: University Hospital, Angers

Location: France

Summary

Shock is a serious complication corresponding to acute circulatory failure resulting in multiorgan failure and death. In order to improve cellular oxygen utilization, several therapies can be used. To select one of them, the monitoring of cardiac output is helpful. However, there are several methods used in current practice in intensive care for evaluating hemodynamic.Currently, in patients with acute circulatory failure, no study has compared the concordance of therapeutic decision-making based on transpulmonary thermodilution or transthoracic echocardiography.The objective of the PICC-ECHO study is thus to assess the concordance of therapeutic decision-making by several experts, based on data from transpulmonary thermodilution or transthoracic echocardiography.Indeed, the investigators hypothesize that performing hemodynamic monitoring based on transpulmonary thermodilution or transthoracic echocardiography does not lead to the same therapeutic management in patients in shock.

Eligibility Criteria

Inclusion Criteria:adult patient, hospitalized in the Intensive Care Medicine, CHU of Angers;patient requiring a hemodynamic evaluation because of an acute circulatory insufficiency defined by : arterial hypotension requiring vasopressor amines, with clinical signs (mottling, encephalopathy, oliguria > 2h) and/or biological signs (pH <7.38; lactate > 2 mmol/L) of tissue hypoperfusion;patient monitored by transpulmonary thermodilution with pulse wave contour measurement (PiCCO) as part of routine care.Exclusion Criteria:patient with acute pulmonary heart on TTE (defined as a LV-to-VG ratio > 0.6 associated with a paradoxical interventricular septum);patient objecting to participation in the research;a relative who has received the information, if the patient's condition does not allow it, and who objects to the participation of his or her relative in the research;persons protected by law.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05613647). StuddyBuddy aggregates publicly available trial information.